Home Applications 076019 Application 076019
Type ANDA
Sponsor HOSPIRA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DEFEROXAMINE MESYLATE DEFEROXAMINE MESYLATE INJECTABLE;INJECTION 500MG/VIAL No No 002 DEFEROXAMINE MESYLATE DEFEROXAMINE MESYLATE INJECTABLE;INJECTION 2GM/VIAL No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076019-001 DEFEROXAMINE MESYLATE DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 A076019-002 DEFEROXAMINE MESYLATE DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP 2004-03-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076019-001 DEFEROXAMINE MESYLATE 500MG/VIAL INJECTABLE / INJECTION AP 2004-03-17 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A076019-002 DEFEROXAMINE MESYLATE 2GM/VIAL INJECTABLE / INJECTION AP RS 2004-03-17 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0409-2336 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2336 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2336 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2336 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2336 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2337 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2337 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2337 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2337 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current 0409-2337 Deferoxamine Mesylate Deferoxamine Mesylate Hospira, Inc. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 22527 ORIG 2006-04-20 31062 ORIG 2004-03-19